Nanocare Technologies, Inc. was founded in 2010 to advance the work of nearly 15 years of A14 development by cofounder and Chief Scientific Officer José Emilio (“Milo”) Fehr Pereira Lopes MD, PhD and cofounder David Katona.



José Emilio Fehr Pereira Lopes, MD PhD

Chief Scientific Officer


José Emilio Fehr Pereira Lopes MD, PhD (“Milo”) has over 25 years of experience in biomedical and medical research and drug development. His expertise spans numerous therapeutic areas, with an emphasis on hematology-oncology and laser wound therapy. Milo spent almost 20 years working on the formulation of A14.

Milo holds a PhD from the University of São Paulo, São Paulo, Brazil (2009). His thesis entitled “Differential dose dependence for pro-angiogenesis and cytotoxic effects of a new anticancer plant agent within a novel nanocarrier formulation” won every award given to a PhD student and was unanimously given highest honors. He also holds a Masters Degree in Optics and Nuclear Physics, 2003 from the University of Sao Paulo in the City of Sao Carlos, Brazil. Milo received his JD from the University of São Carlos, São Paulo, Brazil, 1997 and his MD and BS from the University of Catanduva, São Paulo,1989.  Milo completed his Medical Residency at the University of São Paulo, Brazil in 1993.  Milo has also been a guest professor in the biology of cancer at the faculty of medicine of the University of Sao Paulo- Ribeirao Preto, Brazil.



David Katona


David Katona co-founded Nanocare Technologies, Inc with Dr. Milo Lopes to help chart a course to bring A14 to market.


David has significant experience working on Wall Street in numerous capacities from Investment Banking (healthcare and technology) to Investment Management. David is a Partner of Abundance Partners, LLC having co-founded their venture arm. David is an investor and advisor to a number of technology-based start-up companies.


Prior to Abundance, David co-founded Spruce Point Capital Management, another Manhattan-based equity-focused Hedge Fund. He has launched and been a part of numerous companies in sectors ranging from social media to construction applications.







© NANOCARE 2017               PRIVACY POLICY              LEGAL NOTICE               LEGAL DISCLAIMER               CONTACT US


This site is governed by applicable U.S. laws and governmental regulations. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. To Contact Us or search this site, please see the links on our Home page. All contents © 2013 Nanocare. All rights reserved.